Trevi Therapeutics Inc (TRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | 7,820 | 7,025 | 8,273 | 6,947 | 9,167 |
| Operating Income | -7,820 | -7,025 | -8,273 | -6,947 | -9,167 |
| Interest Expense | 295 | 302 | 309 | 303 | 296 |
| Other Income | 59 | -7 | 56 | -3 | -333 |
| Pre-tax Income | -8,056 | -7,334 | -8,526 | -7,253 | -9,796 |
| Income Tax | -4 | 5 | -2 | -2 | -2 |
| Net Income Continuous | -8,052 | -7,339 | -8,524 | -7,251 | -9,794 |
| Net Income | $-8,052 | $-7,329 | $-8,520 | $-7,255 | $-9,794 |
| EPS Basic Total Ops | -0.14 | -0.24 | -0.23 | -0.34 | -0.49 |
| EPS Basic Continuous Ops | -0.14 | -0.24 | -0.23 | -0.34 | -0.49 |
| EPS Diluted Total Ops | -0.14 | -0.24 | -0.23 | -0.34 | -0.49 |
| EPS Diluted Continuous Ops | -0.14 | -0.24 | -0.23 | -0.34 | -0.49 |
| EBITDA(a) | $-7,741 | $-6,860 | $-8,104 | $-6,783 | $-9,009 |